Rybelsus 3mg Tablet

Rybelsus 3 mg contains Semaglutide which is used to lower blood sugar levels. It is also used to manage weight especially for patients with obesity. It is a glucagon-like peptide-1 (GLP-1) agonist which means it works like the natural GLP-1 hormone in the body. 

Key Features

How does Rybelsus 3 mg work?

Rybelsus 3 mg consists of Semaglutide which is a GLP-1 receptor agonist. GLP-1 is released in the body after eating to help regulate appetite and blood sugar levels. It slows down digestion so that the food stays in the stomach a little longer. It decreases appetite and food intake. 

Directions for use

Always take this medicine as prescribed by the healthcare provider. Below are some tips for better absorption:

• Take the tablet on an empty stomach after a fasting period of at least 8 hours. 
• Swallow the tablet whole. 
• Do not split, crush or chew the tablet. 
• Wait at least 30 minutes before eating, drinking anything other than water. 

Dosage

The starting dose is 3 mg once a day for one month. After one month, your healthcare provider might increase the dose to 7 mg tablets once a day. 

Uses

• Chronic weight management
• Cardiovascular risk reduction
• Type 2 Diabetes

Side effects 

Common side effects are:

• Nausea
• Stomach pain
• Diarrhea
• Vomiting 
• Constipation
• Reduced appetite

Less common side effects are:

• Bloating 
• Indigestion
• Hair loss
• Dizziness
• Burping

Serious side effects are:

• Risk of thyroid lumps
• Pancreatitis
• Hypoglycaemia
• Severe stomach problems
• Serious allergic reactions
• Vision changes

Interactions

• Using sulfonylureas and insulin with Rybelsus might increase the risk of hypoglycaemia. 
• Semaglutide should be avoided with other GLP-1 agonists like Liraglutide, Tirzepatide. 
• Semaglutide delays stomach emptying. This alters the absorption of medications including thyroid medications, oral contraceptives, diuretics, blood pressure medications and pain relievers. 
• Medications like chloroquine and hydroxychloroquine can also increase the risk of hypoglycaemia if combined with Semaglutide. 
• Drugs like furosemide can increase the risk of dehydration.
• Concomitant use of Semaglutide and Levothyroxine can reduce the absorption of thyroid medications.

Precautions & Warnings

• Acute or chronic kidney damage can take place. Use with caution. 
• Semaglutide has a warning for the risk of thyroid C-cell tumours. It should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). 
• Avoid semaglutide if you are pregnant, planning to get pregnant or breastfeeding.
• Delayed gastric emptying can alter the absorption of oral medications taken concurrently. 
• Severe vomiting or diarrhea can lead to dehydration, be caution. 
• It can cause eye problems especially if you have a condition called diabetic retinopathy. 
• Do not use the tablet if you are allergic to Semaglutide or any other ingredient of the tablet. 
• Avoid fatty, greasy, fried and heavily spiced foods as well as sugary items as it can trigger or worsen stomach upset. 
• Avoid alcohol.

Conclusion

Rybelsus 3 mg is an effective and safe oral alternative to most of the injectable solutions. It consists of Semaglutide which is a Glucagon-like peptide type 1 (GLP-1) receptor agonist. When used with a balanced diet, regular exercise and routine medical follow-up, it can play an important role in long-term management of diabetes as well as weight loss. Always use the medication as prescribed only. 

FAQ’s